Global Minimally Invasive Surgical Instruments Market is valued at USD 20.18 Billion in 2021 and expected to reach USD 32.19 Billion by 2028 with a CAGR of 7.38% over the forecast period.
Global Minimally Invasive Surgical Instruments Market: Global Size, Trends, And Competitive, Historical & Forecast Analysis, 2021-2028: Increasing number of surgeries, rising adoption of minimally invasive surgeries, and growing geriatric population are some of the major factors driving the growth of the Global Minimally Invasive Surgical Instruments Market.
Minimally invasive surgical instruments to be defined as “non-invasive” would mean that it does not go into the body. The instruments used in minimally invasive surgeries are known as minimally invasive surgical instruments. Examples of minimally invasive surgical instruments include external bandages, blood pressure monitors, hearing aids, stethoscopes, x-ray, splints, and MRI machines. Minimally invasive surgeries (MIS) are considered of as less painful than ordinary open medical procedures in light of the fact that these open medical procedures are performed with conventional laparoscopic instruments which make it complex. The minimally invasive laparoscopic cameras are for the most part embedded with the help of specific little instruments through little cuts. The patients generally recover quicker after these techniques with lesser pain when compared with other type of medical procedures. Minimally invasive surgery can result in less pain, scarring, and damage to healthy tissues and the patient may recover faster than conventional surgery. Minimally invasive surgery permits surgeon to utilized techniques that limit the size and number of cuts or incisions they may require to make. It is generally considered safer than open surgery.
Covid-19 pandemic has also impacted the growth of the global minimally invasive surgical instruments market. During pandemic, many elective medical procedures were postponed or cancelled worldwide or were on hold or diverted the accessible restricted limits and resources such as hospital beds and patient care experts toward Covid-19 patient care. In addition, the arrangement of cardiovascular medical procedures has been disproportionally impacted because of the reallocation of intensive care resources. However, from 2019-2020, the procedural volume for cardiovascular medical procedure declined considerably, yet it is normal to increment post-pandemic 2021 due on the backlog arising out of this delay. This is supposed further to impel the demand for minimally invasive surgical instruments market.
Report Analysis | Details |
---|---|
Historical data | 2018 - 2021 |
Forecast Period | 2022 - 2028 |
Market Size in 2021: | USD 20.18 Billion |
Base year considered | 2021 |
Forecast Period CAGR %: |
7.38% |
Market Size Expected in 2028: | USD 32.19 Billion |
Tables, Charts & Figures: | 175 |
Pages | 196 |
Minimally Invasive Surgical Instruments Companies | Siemens, Medtronic, Ethicon, Inc. (Johnson & Johnson), Abbott Laboratories, Depuy Synthes, Intutive Surgical, Inc., NuVasive, Inc., Zimmer Biomet, and others. |
Segments Covered | By Device, By Application, By End-Use |
Regional Analysis | North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa |
The global minimally invasive surgical instruments market is segmented on the basis of the device, application, end-use, and region & country level. On the basis of devices, the global minimally invasive surgical instruments market is segmented into electrosurgical devices, monitoring & visualization devices, cutter instruments, guiding devices, handheld instruments, inflation devices, and auxiliary devices. By application, the global minimally invasive surgical instruments market is segmented into gastrointestinal surgery, gynaecological/urological surgery, orthopedic surgery, cosmetic/bariatric surgery, cardiothoracic surgery and others. By end-use, the global market is segmented into ambulatory surgical centers (ASCs), hospitals & clinics.
Some major key players for the global minimally invasive surgical instruments market report cover prominent players like Siemens, Medtronic, Ethicon, Inc. (Johnson & Johnson), Abbott Laboratories, Depuy Synthes, Intutive Surgical, Inc., NuVasive, Inc., Zimmer Biomet, and others.
News- Striker Announced that They have Launched a Procedure Guide for Minimally Invasive Bunion Procedures
On February 24th, 2022; Striker announced that they have launched their new Prostep MICA solo guide for minimally invasive bunion procedures. Kalamazoo, a Michigan-based striker, has designed the Prostep MICA all-in-one procedure guide for use by a single surgeon, eliminating the need for additional surgical assistance during minimally invasive bunion operations.
On November 10th, 2021; Max Hospital launched Da Vinci Xi Surgical Robot to perform robotic-assisted minimally invasive surgeries. The da Vinci system translates a specialist's hand developments at the console in real time, twisting and rotating the instruments while going through the procedure. The Da Vinci Shi surgical robot enables surgeons to perform complex surgeries with increased accuracy and flexibility in a variety of disciplines, including oncology, minimal access, urology, bariatric and robotic surgery, gynecology, thoracic surgery, and general surgery.
On March 30th, 2021; Hitachi Metals, Ltd. (Hereinafter “HML”) announced their revived website for 2021. The new format is designed to help customers navigate more accurately and understand the best medical products and services that HML offers to newcomers around the world. The website highlights a small sample of the company’s many strengths as global manufacturers, catheter tubing for surgical catheters, micro-gauge wire technology for disposable endoscopes or non-sticky silicone for surgical robotics, and complex bundle cables.
One of the major factors driving the growth of the minimally invasive surgical instruments market is the increasing number of surgeries. Surgery is much of the time the only treatment that can lessen disabilities and diminish the risk of death from normal circumstances. The future of a medical procedure will bring innovative technologies, an upgraded understanding of the disease, and more extensive collaboration among specialists and innovators to work on patient care. The main region of surgery is for diagnosis or confirmation, removal of damaged tissue or obstruction, repair or replacement of tissue or organs, implantation of equipment, redirection of blood vessels, or transplantation of tissue or organs. Therefore, an increasing number of surgeries have driven the market. For instance; according to the National Library of Medicine, in September 2020; about 310 million major surgeries are performed every year.
In addition, the rising adoption of minimally invasive surgeries is also boosting market growth. Minimally invasive surgery has a variety of potential benefits such as minimal blood loss, pain and trauma reduction, minimal risk of infection, less noticeable scars, faster recovery, shorter hospitalization, and faster return to normal activities. A low-cost mechanical device has recently been developed to perform low-cost laparoscopic surgery. All these benefits are increasing the trend for these minimally invasive surgeries and supplementing the demand for minimally invasive surgical instruments. For instance; as per the news published, on February 24th, 2022; Stryker launched a procedure guide for minimally invasive bunion procedures.
Moreover, the growing geriatric population is another factor which is boosting the minimally invasive surgical instruments market. For instance; according to United Nation, in 2019, there were 703 million populace aged 65 and the number of geriatric people is anticipated to reach to 1.5 billion by 2050. A rising extent of patients requiring treatment for malignancy is elderly, which has made new difficulties for oncologic specialists. Maturing is related to a rising predominance of frailty and comorbidities that might influence the result of surgeries. By diminishing complications and shortening the length of clinic stay without influencing oncologic security, a medical procedure performed utilizing the robot, as opposed to customary laparotomy, improves the possibilities of an improved result in developing older populaces. Minimally invasive surgeries are less painful and preferred for the old age population.
However, the high cost associated with minimally invasive surgical instruments may hamper the growth of the market. In spite of that, rising interest in outpatient robotic-assisted surgeries can offer an opportunity for the further growth of the market.
North America is Expected to Dominate the Global Minimally Invasive Surgical Instruments Market
Geographically, North America is expected to dominate the global minimally invasive surgical instruments market within the forecast period due to the increasing geriatric population, rising medical tourism for cosmetic surgery, and growing technological advancement in this region. For instance; according to Rural Health Information Hub, on April 6th, 2019; there were 46 million people aged 65 in the U.S. The number of geriatric people is projected to double to 90 million by 2050. And, growing technological advancements area also boosting the growth of the market. For example; in July 2020, Fujifilm Medical Systems USA Inc. launched its ELUXEO surgical method, which contains both the endoscopy and minimally invasive surgery arrangement of the organization and helps specialists in performing adaptable and rigid endoscopy from a solitary tower by giving better visualization.
The Asia Pacific is expected to show the fastest growth in the global minimally invasive surgical instruments market due to increasing demand for minimally invasive surgery and the presence of key players in this region. For instance; as per the news published, on March 30th, 2020; Hitachi Metals, Ltd. launched an innovative website to initiate medical fine-gauge cable worldwide for minimally invasive devices.
North America
Europe
Asia-Pacific
Latin America
The Middle East and Africa
+44-1173181773
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USFIND ASSISTANCE
LONDON OFFICE
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
FOLLOW US
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®